Form 4: Carlsmed Director Kevin O'Boyle Awarded 17,333 Restricted Stock Units

Carlsmed, Inc. Director Kevin C. O'Boyle received an award of 17,333 restricted stock units, which will vest in equal annual installments over three years.

Summary

• Kevin C. O'Boyle, a Director of Carlsmed, Inc. (CARL), was awarded 17,333 restricted stock units (RSUs).
• Each RSU entitles the reporting person to receive one share of Common Stock upon vesting.
• The RSUs will vest in equal annual installments over a period of three years.
• The transaction date for this award was July 22, 2025.
• Following this transaction, O'Boyle beneficially owns 17,333 unvested restricted stock units.

Sentiment

Score: 6

Explanation: Slightly positive as it aligns director interests with shareholders, a common and generally accepted practice for corporate governance.

Positives

• Award of restricted stock units to a director aligns their interests with those of shareholders, incentivizing long-term performance.
• Equity compensation is a common method to attract and retain experienced board members.

Negatives

• Potential for future dilution of existing shareholders upon the vesting and conversion of the restricted stock units into common stock.

Risks

• The value of the restricted stock units is subject to the future performance of Carlsmed, Inc.'s common stock.
• Unvested RSUs carry the risk of forfeiture if vesting conditions (e.g., continued service) are not met.

Future Outlook

The vesting schedule over three years indicates a future issuance of common stock to the director, contingent on continued service.

Industry Context

This transaction is a standard form of equity compensation for directors in publicly traded companies, aiming to align their long-term interests with shareholder value creation.

Comparison to Industry Standards

• Not enough specific information in this Form 4 to compare the size or terms of this RSU award to specific comparable companies or projects. However, equity awards to directors are a common practice across industries.

Corporate Governance

Related Party Transactions

• The award of restricted stock units to Kevin C. O'Boyle, a Director of Carlsmed, Inc., constitutes a related party transaction as it involves compensation to a member of the company's board.

Stakeholder Impact

• Shareholders: Potential for minor dilution upon vesting of RSUs, but also benefits from aligned director incentives.

Next Steps

• Vesting of the 17,333 restricted stock units in equal annual installments over three years.
• Conversion of vested RSUs into common stock.

Key Dates

Keywords

Carlsmed, CARL, Restricted Stock Units, RSU, Director Compensation, Equity Award, Insider Transaction, Form 4, Executive Compensation